Recently, Newman's Health Food Holdings Limited (hereinafter referred to as "Newman's") (02530.HK) was successfully listed on the Main Board of the Hong Kong Stock Exchange. Newman's offered 250 million shares in its global IPO, accounting for 25% of the total shares upon completion of the offering. The offering price was set at the lower limit of HK$0.80 per share, with total proceeds of approximately HK$200 million, and net proceeds of approximately HK$120.5 million. Newman's will not exercise the over-allotment option. The public offering tranche of this IPO was subscribed 65.17 times, while the international offering tranche. According to the prospectus, in the shareholding structure of Newman's after listing, the controlling shareholders, Mr. Wang Ping and Ms. Cui Juan, a couple, respectively hold 91% and 9% of Far East Wealth, with a combined shareholding of 75%; public shareholders hold 25%. Newman's mainly engages in the marketing, sales and distribution of finished nutritional products in China, under its exclusive brands "Xin Mousi" and "Xin Mousi" (English name: Nemans). Its products can be roughly divided into five categories: algal oil DHA, probiotics, vitamins, multi-dimensional nutrients and algal calcium products. In addition, since the 2022 fiscal year, the company has also sold five milk powder products under the brand licensed by Ausnutria Group, generating a small amount of revenue. Newman's positions its nutritional products as high-end and premium ones, targeting consumers including pregnant and post-partum women, infants and children. According to Frost & Sullivan, Newman's is the largest domestic brand in terms of the retail value of algal oil DHA products made from imported raw materials in 2023, with a market share of approximately 20.5%. As of midday trading close, Newman's shares stood at HK$0.65 per share, with a total market capitalization of approximately HK$650 million. The intermediary team for Newman's (02530.HK) this IPO mainly includes: Caitong International as its sole sponsor, sole overall coordinator, joint global coordinator, joint bookrunner and joint lead manager; China Fortune Jianye as its joint global coordinator, joint bookrunner and joint lead manager; Everbright Securities International, First Fidelity Capital, Futu Securities, Phillip Securities, Soochow Securities and Zhongchen Securities as its joint bookrunners; Tongshang and Wenshi as the company's PRC legal counsel and Hong Kong legal counsel respectively; Grandall Law Firm and Coleson, White & Cheung as the underwriters' PRC legal counsel and Hong Kong legal counsel respectively; Frost & Sullivan as its industry advisor. https://www1.hkexnews.hk/listedco/listconews/sehk/2024/1230/2024123000006_c.pdf © 2021 Meishun (Hong Kong) Management Consulting Co., Ltd. and Meishun (Hangzhou) Management Consulting Co., Ltd. All rights reserved. Meishun Meiyin (Hangzhou) Consulting Management Co., Ltd. is a domestic subsidiary of Hong Kong Meishun Management Consulting Co., Ltd. under the same ultimate controlling party. Both companies share the same ultimate controlling party, are under unified China management, and comply with the laws of Hong Kong and the Mainland of China.